Who Owns Blueprint Genetics?
Blueprint Genetics is a genetic testing brand owned by Quest Diagnostics Incorporated (NYSE: DGX), specializing in diagnostics for rare inherited diseases. Founded in 2012 in Helsinki, Finland, it was acquired by Quest in 2020.
Parent Company
Acquired
2020
Status
Publicly Traded
Headquarters
Blueprint Genetics Timeline
GlobalOfficial Website
Who Owns Blueprint Genetics?
- Parent Company: Quest Diagnostics Incorporated
- Ownership Type: Wholly owned
- Acquisition Year: 2020
- Company Type: Publicly Traded
- Stock Ticker: New York Stock Exchange: DGX
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Blueprint Genetics | Quest Diagnostics Incorporated | Wholly owned |
Where to Buy
Disclosure: We may earn commission from purchases
Blueprint Genetics on AmazonAdvertisement
History of Blueprint Genetics
- Founded: 2012
- Founders: Juha Koskenvuo, Tero-Pekka Alastalo, Samuel Myllykangas
- Acquired by Quest Diagnostics Incorporated: 2020
Finnish founders Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas launched Blueprint Genetics in Helsinki in 2012, building high-coverage gene panels for cardiologists, ophthalmologists, and neurologists.
Quest Diagnostics acquired the company in 2020, integrating its panels into Quest's advanced diagnostics menu and expanding its global client base.
Blueprint continues operating from Helsinki and Seattle under its own brand.
Advertisement
About Quest Diagnostics Incorporated
Is Quest Diagnostics publicly traded?
Yes. It trades on the NYSE under ticker DGX.
Did Quest acquire LifeLabs?
Yes. Quest completed the roughly C$1.35 billion acquisition of Canada's LifeLabs in October 2024.
Who is the CEO of Quest Diagnostics?
Jim Davis, chairman, chief executive officer, and president.
How big is Quest Diagnostics?
It serves one in three American adults each year and guides to about $12.1 billion in FY2026 revenue.
Advertisement
- Founded: 1967
- Headquarters: Secaucus, New Jersey, USA
- Company Type: Publicly Traded
- Stock: New York Stock Exchange: DGX
- Revenue: Approximately $12.1 billion (FY2026 guidance)
- Employees: Approximately 55,000
Where Is Blueprint Genetics Made / Based?
- Headquarters: Helsinki, Uusimaa, Finland
Blueprint Genetics Categories & Tags
Brands Owned by Quest Diagnostics Incorporated
Healthcare PharmaceuticalsLifeLabs
Owned by Quest Diagnostics Incorporated
Canada's largest community laboratory brand, owned by Quest Diagnostics since October 2024.
lab-testingdiagnosticscanada
Healthcare PharmaceuticalsQuest Diagnostics
Owned by Quest Diagnostics Incorporated
The flagship clinical laboratory brand of Quest Diagnostics Incorporated, the largest lab testing provider in the United States.
lab-testingdiagnosticsblood-tests
Blueprint Genetics Ownership: Pros & Cons
Advantages
- +Deep rare-disease panel expertise
- +Quest distribution scale
- +International lab footprint
Considerations
- -GeneDx and broad-panel competition
- -Reimbursement variability by market
- -Narrow specialty focus
Advertisement
Frequently Asked Questions About Blueprint Genetics
Sources & Further Reading
- Blueprint Genetics official website
- Quest Diagnostics Incorporated company page - /companies/quest-diagnostics
Advertisement
Competitors to Blueprint Genetics
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Labcorp | USA | 2010 | Mass market | United states | All Genders |
Learn More About Competitors
Competitive Analysis
Market Positioning: Blueprint Genetics competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Advertisement
Independent Alternatives to Blueprint Genetics
Looking for brands with different ownership structures? These similar brands are not owned by Quest Diagnostics Incorporated, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsAvaility
Owned by Availity
The largest real-time health information network in the US, owned by a consortium of major health insurers and Novo Holdings.
healthcare-technologyclearinghouseclaims-processing
Privately Owned
Availity is privately owned, unlike Blueprint Genetics which is under a publicly traded parent company.
Healthcare PharmaceuticalsBand-Aid
Owned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
wound-careadhesive-bandagefirst-aid
Privately Owned
Band-Aid is privately owned, unlike Blueprint Genetics which is under a publicly traded parent company.
Healthcare PharmaceuticalsBenadryl
Owned by Kenvue
American brand of antihistamine medication used to treat allergies, itching, and cold symptoms, manufactured and marketed by Johnson & Johnson.
antihistamineallergy-reliefcold-medicine
Privately Owned
Benadryl is privately owned, unlike Blueprint Genetics which is under a publicly traded parent company.
Healthcare PharmaceuticalsBoots
Owned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
pharmacyhealth-beautyuk-retail
Privately Owned
Boots is privately owned, unlike Blueprint Genetics which is under a publicly traded parent company.
Healthcare PharmaceuticalsDuane Reade
Owned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
pharmacydrugstorenew-york
Privately Owned
Duane Reade is privately owned, unlike Blueprint Genetics which is under a publicly traded parent company.
Healthcare PharmaceuticalsMD Clarity
Owned by MD Clarity
Seattle healthcare SaaS platform for patient cost estimates, payer contract management, and underpayment detection.
healthcare-technologyrevenue-cyclecontract-management
Privately Owned
MD Clarity is privately owned, unlike Blueprint Genetics which is under a publicly traded parent company.
Quest Diagnostics Incorporated Stock Information
Advertisement
Jobs at Quest Diagnostics Incorporated
Latest News About Blueprint Genetics
Advertisement
Related Articles About Blueprint Genetics
View more articles
News & Updates
Monthly IPO Roundup: November 2026 -- October's Biggest Listings
October 2026 IPOs: Jio Platforms set India's all-time record at $3.2B and surged 27%, GCash owner Mynt raised a Philippine-record P60.9B, Anthropic filed publicly for a possible mid-November debut, and U.S. listings were a biotech grab bag. Full recap.
Who Brands StaffNov 6, 2026
Ipo RoundupIpoStock Market
News & Updates
Monthly M&A Roundup: October 2026 Brand Ownership Changes
October 2026's biggest deals: Paramount Skydance closed its $110B Warner Bros. Discovery takeover, Salesforce signed Braze for $5.66B, Proofpoint bought Varonis for $6.3B, the Weston family agreed to buy Boots for $8.9B, and Viatris added Pacira for $1.65B. Full breakdown.
Who Brands StaffNov 6, 2026
M And A RoundupAcquisitionsNews
Rivalry
Duracell vs Energizer: The Battery Brand Rivalry
Duracell is Berkshire Hathaway-owned (25-30% US share). Energizer is publicly traded (NYSE: ENR) with Rayovac. Together they control ~85% of branded US batteries, but Amazon Basics has 27.1% online. Explore our database.
Who Brands StaffOct 23, 2026
DuracellEnergizerRivalry
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Brandspecialty-pharmacy
Accredo
Specialty pharmacy founded in 1996 in Memphis, serving patients with complex and rare conditions as the specialty pharmacy of Evernorth within The Cigna Group.
Brand in Healthcare & Pharmaceuticals
rare-diseaseevernorth